Search Within

GSK Faculty

Formats
  1. Journal Article (13959)
  2. Meeting Abstract (7136)
  3. Review (529)
  4. Book Section (346)
  5. Editorial (315)
  6. Conference Paper (163)
  7. Research Letter (96)
  8. Miscellaneous (46)
  9. Correspondence (38)
  10. Guidelines (33)
  11. Book Whole (24)
Groups
  1. Sloan Kettering Institute Faculty (11554)
  2. Department of Medicine (10642)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (8373)
  4. Tow Center for Developmental Oncology (TCDO) (7023)
  5. Sloan Kettering Institute Postdocs (6327)
  6. Solid Tumor Oncology Division (5941)

More Groups

People
  1. Marc Ladanyi (1335)
  2. Steven Larson (960)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (904)
  5. Kenneth Offit (792)
  6. Ross Levine (787)

More People

Years
  1. 2025 (483)
  2. 2024 (904)
  3. 2023 (1015)
  4. 2022 (1148)
  5. 2021 (1087)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1506)
  2. Journal of Clinical Oncology (1295)
  3. Cancer Research (1105)
  4. Clinical Cancer Research (531)
  5. Modern Pathology (497)
  6. Journal of Nuclear Medicine (476)

More Publications

Publishers
  1. Nature Publishing Group (2630)
  2. American Association for Cancer Research (2205)
  3. Elsevier Inc. (1882)
  4. American Society of Hematology (1590)
  5. Cell Press (1442)
  6. American Society of Clinical Oncology (1398)

More Publishers

Results (22685)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The FXR1 network acts as a signaling scaffold for actomyosin remodeling
    Journal Article

    Chen, X.; Fansler, M. M.; Janjoš, U.; Ule, J.; Mayr, C.
    Cell (2024)

    Fulltext@MSK | Save
  • Dotting out AML by targeting fibrillarin
    Editorial

    Luo, H.; Kharas, M. G.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation
    Journal Article

    Yaeger, R.; McKean, M. A.; Haq, R.; Beck, J. T.; Taylor, M. H.; Cohen, J. E.; Bowles, D. W.; Gadgeel, S. M.; Mihalcioiu, C.; Papadopoulos, K. P.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Precision oncology: Current and future platforms for treatment selection
    Review

    Tang, X.; Berger, M. F.; Solit, D. B.
    Trends in Cancer (2024)

    Fulltext@MSK | Save
  • Ubiquitin system mutations in neurological diseases
    Review

    Zenge, C.; Ordureau, A.
    Trends in Biochemical Sciences (2024)

    Fulltext@MSK | Save
  • Engineering immune-evasive allogeneic cellular immunotherapies
    Review

    Martin, K. E.; Hammer, Q.; Perica, K.; Sadelain, M.; Malmberg, K. J.
    Nature Reviews Immunology (2024)

    Fulltext@MSK | Save
  • Obscure DNA sequences unveil a new cancer target
    Editorial

    Sfeir, A.
    Nature Structural and Molecular Biology (2024)

    Fulltext@MSK | Save
  • Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors
    Journal Article

    Nigam, A.; Krishnamoorthy, G. P.; Chatila, W. K.; Berman, K.; Saqcena, M.; Walch, H.; Venkatramani, M.; Ho, A. L.; Schultz, N.; Fagin, J. A.; more...
    Oncogene (2024)

    Fulltext@MSK | Save
  • Broad-spectrum antibiotics disrupt homeostatic efferocytosis
    Journal Article

    Saavedra, P. H. V.; Trzeciak, A. J.; Lipshutz, A.; Daman, A. W.; O’Neal, A. J.; Liu, Z. L.; Wang, Z.; Romero-Pichardo, J. E.; Rojas, W. S.; Zago, G.; more...
    Nature Metabolism (2024)

    Fulltext@MSK | Save
  • Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: A phase 1b/2a trial
    Journal Article

    Horwitz, S. M.; Nirmal, A. J.; Rahman, J.; Xu, R.; Drill, E.; Galasso, N.; Ganesan, N.; Davey, T.; Hancock, H.; Perez, L.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save